Definitely 2015 can be considered MedLife’s year, with strategic investments, opening new clinics, entering new lines of business and recording good financial results.
Thus, MedLife just announced on Thursday entering a new healthcare segment as the private operator launched the process of purchasing the majority stake of Stem Cells Bank in Timisoara, one of the most advanced and well equipped stem cell banks in Southeast Europe, a press release informs.
According to Mihai Marcu, President of MedLife’s Board, the decision to enter this new line of business represents a natural step in the business development of the private health operator, thus strengthening its leading position in western Romania.
“We have over 3,500 births annually in our three maternities, the highest number of births in the private sector, and, once the integration of this new service, we will be able to offer complete solutions for mother and child in own regime, in monitoring pregnancy and childbirth, in storing stem cells and childcare, all under the MedLife umbrella,” Marcu said.
Stem Cells Bank was opened in 2010 in Timisoara and it’s the stem cell bank with the most modern processing system in Romania, based on Biosafe SEPAX 2 technology and also the only private bank of stem cells in the Balkan region that uses this technology of stem cell processing and isolation which is fully automated. Any risk of contamination in the laboratory is removed.
For 2015, MedLife targets a turnover of EUR 100 million and will continue the acquisition plans at regional level, ‘with the declared intention as the largest operator of medical services in Romania to remain a company with Romanian majority capital.’